IN2015DN02546A - - Google Patents
Info
- Publication number
- IN2015DN02546A IN2015DN02546A IN2546DEN2015A IN2015DN02546A IN 2015DN02546 A IN2015DN02546 A IN 2015DN02546A IN 2546DEN2015 A IN2546DEN2015 A IN 2546DEN2015A IN 2015DN02546 A IN2015DN02546 A IN 2015DN02546A
- Authority
- IN
- India
- Prior art keywords
- particles
- virus
- recombinant
- recombinant infectious
- infectious particles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18421—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18441—Use of virus, viral particle or viral elements as a vector
- C12N2760/18443—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18441—Use of virus, viral particle or viral elements as a vector
- C12N2760/18444—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306176.4A EP2712871A1 (fr) | 2012-09-27 | 2012-09-27 | Virus de la rougeole recombinés exprimant des polypeptides du virus du chikungunya et leurs applications |
| PCT/EP2013/070137 WO2014049094A1 (fr) | 2012-09-27 | 2013-09-26 | Virus de la rougeole recombinant exprimant des polypeptides du virus chikungunya et ses applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN02546A true IN2015DN02546A (fr) | 2015-09-11 |
Family
ID=46982495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2546DEN2015 IN2015DN02546A (fr) | 2012-09-27 | 2013-09-26 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9655961B2 (fr) |
| EP (2) | EP2712871A1 (fr) |
| JP (1) | JP6251273B2 (fr) |
| KR (1) | KR102077131B1 (fr) |
| CN (1) | CN104918952B (fr) |
| AU (1) | AU2013322635C1 (fr) |
| BR (1) | BR112015006763B1 (fr) |
| CA (1) | CA2884585C (fr) |
| DK (1) | DK2900687T3 (fr) |
| ES (1) | ES2682268T3 (fr) |
| HK (1) | HK1211951A1 (fr) |
| IN (1) | IN2015DN02546A (fr) |
| MX (1) | MX359981B (fr) |
| PH (1) | PH12015500499A1 (fr) |
| PT (1) | PT2900687T (fr) |
| SG (1) | SG11201502411PA (fr) |
| WO (1) | WO2014049094A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI111811B (fi) * | 1998-06-05 | 2003-09-30 | Outokumpu Oy | Menetelmä kuivauksen tehostamiseksi |
| US10420830B2 (en) * | 2015-01-29 | 2019-09-24 | Agency For Science, Technology And Research | Nanocapsules carrying chikungunya-associated peptides |
| ES2809508T3 (es) * | 2015-10-06 | 2021-03-04 | Invectys | Estructuras artificiales de poliepítopos para uso en inmunoterapia |
| EP3184119A1 (fr) | 2015-12-23 | 2017-06-28 | Themis Bioscience GmbH | Chromatographie basée sur des stratégies de purification pour les virus de la rougeole basés sur un échafaudage |
| WO2017221076A1 (fr) | 2016-06-24 | 2017-12-28 | Institut Pasteur | Prévention de maladies infectieuses par l'utilisation de composés faits à partir particules interférentes dysfonctionnelles du virus de la rougeole (vr). |
| EP3484508A4 (fr) * | 2016-07-15 | 2020-03-25 | Etubics Corporation | Compositions et procédés pour la vaccination contre les alphavirus |
| KR101919403B1 (ko) * | 2016-11-04 | 2018-11-16 | 연세대학교 원주산학협력단 | 재조합 단백질 및 그의 용도 |
| EP3412307A1 (fr) * | 2017-06-07 | 2018-12-12 | Institut Pasteur | Virus de la rougeole recombinés exprimant des protéines du virus de zika et leurs applications |
| JP7301811B2 (ja) * | 2017-09-21 | 2023-07-03 | ヴァルネヴァ エスイー | 免疫原性チクングニアウイルスｃｈｉｋｖ－ｄｅｌｔａ ５ｎｓｐ３を含む医薬組成物を製造する方法 |
| EP3707154A1 (fr) | 2017-11-09 | 2020-09-16 | Institut Pasteur | Polyépitope chimérique du virus zika comprenant des protéines non structurales et son utilisation dans une composition immunogène |
| JP7359390B2 (ja) * | 2018-02-09 | 2023-10-11 | 国立大学法人大阪大学 | チクングニアウイルスに対する抗体またはその抗原結合断片、およびその用途 |
| EP3581646A1 (fr) | 2018-06-15 | 2019-12-18 | Themis Bioscience GmbH | Système chromatographique et de fabrication intégré pour la production de virus |
| CN109536464B (zh) * | 2018-12-10 | 2022-06-10 | 中国科学院武汉病毒研究所 | 一种缺失衣壳蛋白基因的基孔肯雅病毒感染性克隆及构建方法和在制备减毒疫苗中的应用 |
| CN115433741A (zh) * | 2022-06-23 | 2022-12-06 | 广西大学 | 盖他病毒为载体表达报告蛋白的重组病毒的构建方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2110382A1 (fr) | 2002-06-20 | 2009-10-21 | Institut Pasteur | ADNc infectieux pour une souche de vaccin améliorée du virus de la rougeole Utilisation pour compositions immunogènes |
| CA2545597A1 (fr) | 2006-03-15 | 2007-09-15 | Institut Pasteur | Nouvelles souches isolees et purifiees du virus chikungunya et sequences de polynucleotides et de polypeptides, utilisations immunogenes et diagnostiques connexes |
| EP1939214B1 (fr) | 2006-12-22 | 2013-07-10 | Institut Pasteur | Cellules et méthodes pour générer des virus à ARN, non-segmenté et de brin négatif |
| WO2009124312A2 (fr) * | 2008-04-04 | 2009-10-08 | The Trustees Of The University Of Pennsylvania | Séquences consensus de protéines du virus chikungunya, molécules d’acide nucléique codant pour celles-ci, et compositions et procédés d’utilisation de celles-ci |
| EP2370455B1 (fr) * | 2008-11-26 | 2019-07-03 | Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | Compositions de particule de type viral et procédés d'utilisation |
| PT2519266T (pt) | 2009-12-31 | 2017-11-10 | Medigen Inc | Vacinas de dna infeccioso contra o vírus chikungunya |
| WO2012106356A2 (fr) * | 2011-01-31 | 2012-08-09 | GOVERNMENT OF THE USA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES | Particules pseudo-virales et procédés d'utilisation |
| CN102321639B (zh) * | 2011-09-08 | 2013-06-26 | 中国疾病预防控制中心病毒病预防控制所 | 基孔肯雅病毒病毒样颗粒的制备方法和应用 |
| SG10201606635SA (en) * | 2012-02-16 | 2016-10-28 | Vlp Therapeutics Llc | Virus like particle composition |
| US8961995B2 (en) * | 2012-09-20 | 2015-02-24 | Uab Research Foundation | Methods and compositions for alphavirus replicons |
-
2012
- 2012-09-27 EP EP12306176.4A patent/EP2712871A1/fr not_active Withdrawn
-
2013
- 2013-09-26 IN IN2546DEN2015 patent/IN2015DN02546A/en unknown
- 2013-09-26 SG SG11201502411PA patent/SG11201502411PA/en unknown
- 2013-09-26 BR BR112015006763A patent/BR112015006763B1/pt active IP Right Grant
- 2013-09-26 KR KR1020157010848A patent/KR102077131B1/ko active IP Right Grant
- 2013-09-26 WO PCT/EP2013/070137 patent/WO2014049094A1/fr active Application Filing
- 2013-09-26 MX MX2015003717A patent/MX359981B/es active IP Right Grant
- 2013-09-26 US US14/430,975 patent/US9655961B2/en active Active
- 2013-09-26 PT PT137711065T patent/PT2900687T/pt unknown
- 2013-09-26 DK DK13771106.5T patent/DK2900687T3/en active
- 2013-09-26 EP EP13771106.5A patent/EP2900687B1/fr active Active
- 2013-09-26 CN CN201380055697.6A patent/CN104918952B/zh active Active
- 2013-09-26 CA CA2884585A patent/CA2884585C/fr active Active
- 2013-09-26 AU AU2013322635A patent/AU2013322635C1/en active Active
- 2013-09-26 ES ES13771106.5T patent/ES2682268T3/es active Active
- 2013-09-26 JP JP2015533592A patent/JP6251273B2/ja active Active
-
2015
- 2015-03-09 PH PH12015500499A patent/PH12015500499A1/en unknown
- 2015-12-28 HK HK15112751.7A patent/HK1211951A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2900687B1 (fr) | 2018-05-02 |
| JP2015532090A (ja) | 2015-11-09 |
| HK1211951A1 (en) | 2016-06-03 |
| ES2682268T3 (es) | 2018-09-19 |
| US20150238592A1 (en) | 2015-08-27 |
| KR20150058506A (ko) | 2015-05-28 |
| WO2014049094A1 (fr) | 2014-04-03 |
| KR102077131B1 (ko) | 2020-04-09 |
| AU2013322635A1 (en) | 2015-04-02 |
| BR112015006763A2 (pt) | 2019-09-03 |
| MX2015003717A (es) | 2015-10-22 |
| SG11201502411PA (en) | 2015-04-29 |
| JP6251273B2 (ja) | 2017-12-20 |
| AU2013322635B2 (en) | 2017-10-12 |
| US9655961B2 (en) | 2017-05-23 |
| CA2884585C (fr) | 2021-12-14 |
| AU2013322635C1 (en) | 2018-02-08 |
| PH12015500499B1 (en) | 2015-04-27 |
| PT2900687T (pt) | 2018-08-06 |
| CN104918952A (zh) | 2015-09-16 |
| EP2712871A1 (fr) | 2014-04-02 |
| PH12015500499A1 (en) | 2015-04-27 |
| BR112015006763B1 (pt) | 2023-10-24 |
| CN104918952B (zh) | 2019-01-22 |
| MX359981B (es) | 2018-10-18 |
| CA2884585A1 (fr) | 2014-04-03 |
| DK2900687T3 (en) | 2018-08-06 |
| EP2900687A1 (fr) | 2015-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015500499A1 (en) | Recombinant measles virus expressing chikungunya virus polypeptides and their applications | |
| MX2021006931A (es) | Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos. | |
| PH12015500931A1 (en) | Recombinant particle based vaccines against human cytomegalovirus infection | |
| GB2513768A (en) | Complexes of cytomegalovirus proteins | |
| MX354516B (es) | Vectores que codifican el factor de viabilidad de conos derivado de bastones. | |
| MX350274B (es) | Vacunas para hsv-2. | |
| WO2016046234A3 (fr) | Protéines recombinées sans phe destinées à être utilisées dans le traitement de la phénylcétonurie | |
| PH12019500591A1 (en) | Canine adenovirus vectors | |
| PH12016502554B1 (en) | A dengue virus chimeric polyepitope composed of fragments of non structural proteins and its use in an immunogenic composition against dengue virus infection | |
| MX2019014674A (es) | Virus recombinante de sarampion que expresa proteinas de virus zika y sus aplicaciones. | |
| ZA202003070B (en) | Lassa vaccine | |
| MX2019000215A (es) | Composiciones inmunogenicas a base de listeria que comprenden antigenos de proteinas del tumor de wilms y metodos para su uso. | |
| WO2016116905A9 (fr) | Antigènes de cmv et leurs utilisations | |
| PH12017500450A1 (en) | Flavivirus virus like particle | |
| WO2012038832A3 (fr) | Génération de particules recombinantes chimères virus de la rougeole - rétrovirus | |
| MX2018000023A (es) | Particulas semejantes a virus recombinantes que utilizan la proteina gag del virus de inmunodeficiencia bovina. | |
| MX358507B (es) | Antigenos vacunales quimericos contra el virus de la hepatitis c. | |
| WO2014060851A3 (fr) | Compositions immunogènes contre le virus de l'hépatite c et procédés pour l'utiliser | |
| WO2014151687A3 (fr) | Compositions et procédés pour traiter le sida | |
| WO2013055326A3 (fr) | Vaccins pour le papillomavirus humain et leurs procédés d'utilisation | |
| EP2632942A4 (fr) | Protéine d'enveloppe recombinante du virus de l'immunodéficience humaine (vih) et vaccin la contenant | |
| MX2015011064A (es) | Vacuna contra el virus de la leucemia bovina. | |
| WO2014152271A8 (fr) | Protéines virales en tant qu'agents immunomodulateurs et composants de vaccin | |
| MX2015011485A (es) | Nuevas vacunas contra multiples subtipos del virus del dengue. | |
| MY185444A (en) | Enterovirus 71 antiviral peptides |